Progressive Care Inc (RXMD)

[MrMike241]

$RXMD Due Diligence - Verifiable Facts

$RXMD is a UNICORN and Significantly Undervalued! IMO, decide for yourself...

The best is yet to come!

* 2020 $40.6M REVENUE, walking the profitability line!

* 2021 will be profitable because of operations consolidations, now complete, and new profit center expansion, IMO.

* CEO letter on 9/16/2020, PR below, mentions organic path to $100M REVENUE!

* S-1 FILED with SEC, confidential to the public, to protect their secret expansion plan.

* $RXMD is in MANDATORY Quiet Period before expected NASDAQ Uplist.

* $RXMD has stated that transformative changes are coming!

* $RXMD is expanding to technology sales, telehealth, and pharmaceutical processing with metrics.

* Many initiatives, and acquisition rumors, see DD links below.

* New Keycentrix Partnership announced TODAY, with RXMD implementing Newleaf, a best-in-class pharmacy software solution, PR below, with statement from Keycentrix included. The $RXMD CEO stated that the software platform will "accelerate our health-tech evolution," and "should substantially improve our market positioning in our most scalable and fastest growing segment, which is our reporting capabilities, data management, and data analytics." (supports ClearMetrX service scalability!)

* New EagleForce Health Partnership announced last week, PR below with statement from EagleForce Health included. The $RXMD CEO stated that this partnership will "scale more of our operations in a geographically agnostic manner" (Telehealth Web! National! International?)

* MyApps Partnership benefits both companies by perfecting the CallingDr App, and all RXMD technology implementations, including ClearMetrX. RXMD wanted to acquire MyApps for shares, but the shareholders were vocally unhappy, and RXMD announced a win-win Partnership instead, PR below.

* OS only 485M!

* Market Cap still low at $51M!

* $RXMD is worth $150M if sold Privately, estimated on Telegram by a friend of the founder, and it is easy to justify that number just based on REVENUE, assets, and growth momentum.

* Public company multiple should be at least 3X $450M with current initiatives, perhaps higher because of unknowns in confidential S-1, IMO

* $450M fair valuation puts PPS at $.93! With NASDAQ uplist, M&A rumor, technology expansion, and everything else in the pipeline including organic growth, speculation and momentum could drive PPS much higher, perhaps enough to uplist!! IMO

* OTCQB Member Since 12/2017, Penny Stock Exempt, Transfer Agent Verified, Independent Directors

* No viable trips exist! $RXMD is a UNICORN! If you check it out, you'll see the value!!

RXMD Investor Deck 2021

CEO letter to shareholders with path to $100M REVENUE

PR RXMD Processing Platform Partnership with Keycentrix

Keycentrix.com

PR RXMD Telehealth Partnership with EagleForce Health

EagleForce: Interoperability of healthcare... big data

EagleForce: Telehealth Partnerships

theeagleforce.net

MyApps Partnership, including CallingDr App and ClearMetrX

CallingDr.com

$NETE M&A Rumor

INSTATRADER's DD Pack

RXMD Annual Revenue Growth History 2013 - 2020

ProgressiveCareUS.com

PharmCoRx.com

ClearMetrX.com

facebook.com/ProgressiveCareUS

facebook.com/PharmCoRx

facebook.com/ClearMetrX

twitter.com/ProgressCareUS

twitter.com/PharmCoRx

twitter.com/ClearMetrX

otcmarkets.com/stock/RXMD/news

otcmarkets.com/stock/RXMD/disclosure

otcmarkets.com/stock/RXMD/security

investorshub.advfn.com/Progressive-Care-Inc-RXMD-19843

$RXMD has been under attack for years, ever since the former CEO took action to force naked shorts to cover. IMO, it is the only reason that the PPS is so low.

Progressive Care Updates Shareholders on the Status of Naked Shorts
May 1, 2018.
https://www.globenewswire.com/news-release/2018/05/01/1494089/0/en/Progressive-Care-Updates-Shareholders-on-the-Status-of-Naked-Shorts.html

High Speed Trading Firm... going to war with the SEC
Message Board Thread

$5 PPS uplist scenario. For argument's sake, let's say PPS rises and holds at $5. When we uplist, the company could offer 20M new shares, which I believe would be gobbled up primarily by institutions and other strong hands. That would result in the company gaining $100M capital to fund expansion, with very little dilution impact. In fact, upon uplist we'd probably experience a rise in PPS. That is a win win scenario and a windfall for both the company and existing shareholders. I believe it's at least a possibility, if we can gain enough interest here. I believe RXMD is a UNICORN simply because that's possible; and I believe RXMD deserves that attention! I would certainly retire, just like our former CEO! Think about that fact.

Good Luck RXMD!
$$$,$$$,$$$